Related Articles
Progress in the chemotherapeutic treatment of osteosarcoma (Review)
MicroRNA-126 enhances the sensitivity of osteosarcoma cells to cisplatin and methotrexate
Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents
Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1
S-phase kinase-associated protein 2 is involved in epithelial-mesenchymal transition in methotrexate-resistant osteosarcoma cells